infliximab
ItalyDrugs containing this active substance
-
It is used in adults to treat inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), and psoriasis. It is also indicated for adults and children aged 6 years and older for Crohn's disease and ulcerative colitis.
Form: powder for concentrate for infusion solution
Active substance Dosage infliximab - ATC: L04AB02
Manufacturer: SAMSUNG BIOEPIS NL B.V.
-
It is used in adults to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), and psoriasis. It is also indicated for adults and children aged 6 years and older for Crohn's disease and ulcerative colitis.
Form: solution for infusion, concentrate
Active substance Dosage infliximab - ATC: L04AB02
Manufacturer: PFIZER EUROPE MA EEIG
-
It is used for the treatment of several inflammatory diseases in adults, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), and psoriasis. It is also indicated for adults and children aged 6 years and older for Crohn's disease and ulcerative colitis.
Form: powder for concentrate for infusion solution
Active substance Dosage infliximab - ATC: L04AB02
Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.
-
Remsima is used in adults for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), psoriasis, Crohn's disease, and ulcerative colitis. It works by reducing inflammation by blocking a protein called TNF alpha.
Form: powder for concentrate for infusion solution
Active substance Dosage infliximab - ATC: L04AB02
Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT
-
Zessly is used in adults to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), psoriasis, ulcerative colitis, and Crohn's disease. In adults and children aged 6 years and older, it is also indicated for Crohn's disease and ulcerative colitis.
Form: powder for concentrate for infusion solution
Active substance Dosage infliximab - ATC: L04AB02
Manufacturer: SANDOZ GMBH